2002 Keystone Conference Updates
Publication • 2002by Richard Jeffreys May 2002 Every year, Keystone Symposia sponsor two parallel conferences on HIV pathogenesis and vaccines. The meetings take place at the Keystone Resort high in the Rocky Mountains, allowing researchers to mix the latest data with a daytime trip to the ski slopes. This year’s event offered no earth-shattering new insights, but…
TAG at Ten: The Year 1998
TAGline • 2002January: TAG community meeting at which John Moore gives update on vaccine research. TAG board member Marvin Shulman says farewell to New York life and heads for a full-time residency in South Miami Beach. FDA approves dental dams. Monica Lewinsky scandal erupts. Michael Marco finishes The OI Report, version 2.0. March: Glaxo announces 67 percent…
Suivez La Piste: HIV-Specific CD4 Cell, Holy Grail of Immune Control, Is Hunted Down in Paris Laboratory
TAGline • 2002HIV-Specific CD4 Cell, Holy Grail of Immune Control, Is Hunted Down in Paris Laboratory By Richard Jefferys “An Antibody Called IgG2” It’s been five years since Bruce Walker and his Harvard colleagues first proposed the key role of CD4 T cells primed specifically to target HIV. These cells, Walker (and later other groups) hypothesized, may…
Basic Science Review
Publication • 2002This is the first in a series of periodic reviews of the scientific literature that the Basic Science Project will be making available via the TAG website. September 2002 Exploding CD4 T Cell Counts STIs in Chronic Infection: Predicting Success Trouble at the Nodes? Coughing Up CAF Striking the Balance T Cell Crosstalk: Communication Via…
Enemies at the Gate: Storming Montréal’s Palais de Congrès, and Makeshift Battle Stations in Fortress San Francisco
TAGline • 2002Storming Montréal’s Palais de Congrès, and Makeshift Battle Stations in Fortress San Francisco By David Barr Bodyguarded Investigators It could be said that NIH-activist relations reached their untenable nadir in 1990. Nearly 30,000 Americans had died of AIDS the previous year, and the National Academy of Sciences announced that the disease would cause more than…
TAG at Ten: The Year 1994
TAGline • 2002Jan 7: FDA approves Bactrim and Septra (trimethoprim/sulfamethoxazole) for prevention against PCP — fourteen years after the first AIDS PCP cases were reported. Jan 18: TAG meets with Genetics Institute about IL-12 study results. (The IL-12 treated monkeys had died.) Jan 21: Obscure struggles in D.C. over OAR’s consolidated budget authority resolved in OAR’s favor,…
Re-Infection Data Summarized
TAGline • 2002By Richard Jefferys A Patient With HIV-1 Superinfection New England Journal of Medicine, September 5, 2002, (Stephanie Jost, et al.) A case report involving one 38 year old male, initially diagnosed with acute HIV infection in November 1998. At that time, anti-HIV antibodies were not yet detectable and the viral load was 805,000 copies. He…
Co-Conspirators: HIV Spread Threatens Decade’s Tuberculosis Treatment/Prevention Success
TAGline • 2002HIV Spread Threatens Decade’s Tuberculosis Treatment/Prevention Success By Daniel Raymond New Challenges, Questions TB researchers and policy-makers from around the world gathered on 3-5 June 2002 in Washington, D.C., at the 4th World TB Congress (the 3rd was held ten years ago) to mark progress and map out the next stages of the global campaign…
Community Rx: Scrapping Volunteer Model Meant Curtains for Activist Conscripts and Paved Way for TAG Ascendency
TAGline • 2002Scrapping Volunteer Model Meant Curtains for Activist Conscripts and Paved Way for TAG Ascendency By David Barr “Urgent Need to Teach, Train” Survey the leadership of major AIDS advocacy organizations, scan the mastheads of treatment publications, and chances are you’ll come across name after name of T+D and TAG alumni/ae. Peppered throughout the ranks of…
Once We Were Warriors
TAGline • 2002Activist Corpses Borne in Protest, Furtive Legislative Coups, and the Devastation That Was Berlin By Mark Harrington “We’re Scientists Not Alchemists” Unlike clinical research in AIDS, basic research has not had a powerful constituency to advocate on its behalf. The relevance of basic science to the lives of PWAs is far less apparent than clinical…